(RTTNews) - Avidity Biosciences, Inc. (RNA) reported positive AOC 1001 data from the preliminary assessment of the Phase 1/2 MARINA trial showing the first-ever successful targeted delivery of RNA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results